Prospect Law has extensive experience of advising on legal issues relating to the Pharmaceuticals, Biotechnology and Biopharmaceuticals industries, Clinical Research Organisations and the specialist wholesale distribution of medicines.

Particular Areas of Expertise:

  • Intellectual Property licensing of pharmaceuticals, including in-licences from, and out-licences to, third parties;
  • Distribution agreements for pharmaceutical products in the UK, EU and globally;
  • Terms and conditions of purchase and sale of medical products and items used for manufacturing and research purposes;
  • Clinical Trial Agreements between pharma companies and Clinical Research Organisations;
  • ABPI Code of Practice for the promotion of medicines; making claims against, and defending claims from, other pharma companies alleging breach of the ABPI Code which is administered by the Prescription Medicines Code of Practice Authority;
  • Data privacy and GDPR including the anonymisation/pseudonymisation of patient personal data in clinical trials, the holding of personal data on medical practitioners and also the transfer of personal data outside the UK/EEA, and to the US in particular, following the CLOUD Act in the US and the Schrems II case in the ECJ;
  • Contract-manufacturing agreements and templates;
  • Regulatory matters involving the MHRA in respect of medicines and medical devices;
  • Research and collaboration agreements with third parties, including universities and other research organisations.

Life Sciences Insights:

The Medicines and Medical Devices Act 2021: Stated aims and significance, 10th May 2021

European Commission asserts jurisdiction to review merger of two US corporations – Illumina Inc. files annulment suit in response, 4th May 2021

For more information contact:

David McIntosh on +44 (0) 7483 300 132 or by email on